Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeEXECUTIVESImperative Care Appoints COO Daniel Davis as President and Member of Board of Directors

Imperative Care Appoints COO Daniel Davis as President and Member of Board of Directors


Imperative Care announced they have appointed Chief Operating Officer Daniel Davis as President and Member of their Board of Directors.

Imperative Care notes Daniel Davis will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. He will retain his role as COO and join the company’s Board of Directors.

Daniel Davis has more than 20 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical devices companies, with much of his experience focused on bringing neurovascular innovations to market. Prior to joining Imperative Care in 2019, Mr. Davis served as Chief Commercial Officer and President of North America at Penumbra, Inc., where he led the launch of the first FDA-cleared aspiration system for neurovascular mechanical thrombectomy.

“It’s been a real pleasure working with Daniel and benefiting from his steadfast commitment to elevating stroke care which has enabled him to make significant contributions from the outset of his time at Imperative Care. I am thrilled to see his leadership grow within the organization as he now oversees our efforts to bring much-needed innovation to the field of stroke,” said Fred Khosravi, Imperative Care’s founding Chairman and CEO.

“Many of us at Imperative Care are driven by our personal connection to stroke and the pursuit of better, more streamlined care for stroke patients and their families,” said Mr. Davis. “Imperative Care’s resolute dedication to innovation across the continuum of stroke care has been inspirational to me. I am convinced that this will position the company to revolutionize the stroke space and excited to continue leading the company alongside Fred and our seasoned leadership team.”

Imperative Care is currently commercializing two platforms that offer physicians new capabilities to treat their patients, the industry’s first Large Distal Platform™ (LDP™) access technology, including TracStar LDP™, and unparalleled thrombectomy technology, the Zoom™ Stroke Solution. The company is also developing a pipeline of additional stroke-care innovations.

Stroke remains a largely unaddressed problem that affects over 800,000 Americans each year.1 Treatment options have significantly improved over the last decade, but the need for improved effectiveness and efficiency remains. Imperative Care aims to invest significantly in clinical evidence to advance the standard of care for stroke patients worldwide.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy